Minimally invasive therapies for hepatocellular carcinoma: narrowing the gaps

Abstract

With increasing awareness of the HCC epidemic around the globe, early diagnosis of tumors provides a greater opportunity to benefit patients from liver-directed treatments including surgical resection, ablation, catheter-based therapies and external beam radiation. Development of new approaches and refinement of existing techniques have improved our capabilities to provide efficacious and safe means of local disease control. The choice of treatment for individual patients hinges heavily on factors related to the tumor, underlying hepatic function, and existing co-morbidities. Recent advances in minimally invasive therapies across all disciplines have augmented our ability to eradicate the tumor while preserving liver parenchyma. In this review, we discuss and summarize current minimally invasive options that are available to treat HCCs that are confirmed to the liver, especially in their early stages. Emerging evidence suggest that resection, ablation and radiation can all provide excellent local control, and this opens more options for patients to best suit their needs.

Keywords

Resection / ablation / chemoembolization / radioembolization / Yttrium-90 / radiation / laparoscopic / robotic

References

[1] Collaboration GBoDLCThe burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015..JAMA Oncol2017;3:1683-91 PMCID:PMC5824275

[2] Ryerson AB,Altekruse SF,Jemal A.Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer..Cancer2016;122:1312-37 PMCID:PMC4840031

[3] Cherqui D,Hammoud R,Stephan F.Laparoscopic liver resections: a feasibility study in 30 patients..Ann Surg2000;232:753-62 PMCID:PMC1421268

[4] Koffron AJ,Kung R.Evaluation of 300 minimally invasive liver resections at a single institution: less is more..Ann Surg2007;246:385-92; discussion 92-4 PMCID:PMC1959347

[5] Nguyen KT,Geller DA.World review of laparoscopic liver resection-2,804 patients..Ann Surg2009;250:831-41

[6] Rao A,Ahmed I.Laparoscopic vs. open liver resection for malignant liver disease. A systematic review..Surgeon2012;10:194-201

[7] Vigano L,Laurent A.Laparoscopic liver resection: a systematic review..J Hepatobiliary Pancreat Surg2009;16:410-21

[8] Bagante F,Strasberg SM,Thompson V.Minimally invasive vs. open hepatectomy: a comparative analysis of the national surgical quality improvement program database..J Gastrointest Surg2016;20:1608-17

[9] Parks KR,Davis JM,Hagopian EJ.Laparoscopic versus open liver resection: a meta-analysis of long-term outcome..HPB (Oxford)2014;16:109-18 PMCID:PMC3921005

[10] Thornblade LW,Ruiz A,Park JO.Comparative effectiveness of minimally invasive surgery and conventional approaches for major or challenging hepatectomy..J Am Coll Surg2017;224:851-61 PMCID:PMC5443109

[11] Wakabayashi G,Geller DA,Kaneko H.Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka..Ann Surg2015;261:619-29

[12] Salloum C,Malek A,Azoulay D.Robot-assisted laparoscopic liver resection: a review..J Visc Surg2016;153:447-56

[13] Sham JG,Seo YD,Yeung RS.Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?.J Robot Surg2016;10:307-13

[14] Jackson NR,Hu T,Slakey DP.The safety and efficacy of approaches to liver resection: a meta-analysis..Jsls2015;19:e2014.00186 PMCID:PMC4379861

[15] Qiu J,Chengyou D.A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms..Surg Endosc2016;30:862-75

[16] Montalti R,Patriti A,Troisi RI.Outcomes of robotic vs laparoscopic hepatectomy: a systematic review and meta-analysis..World J Gastroenterol2015;21:8441-51 PMCID:PMC4507115

[17] Sandro R,Laura R,Torello VF.Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study..Hepatology2011;53:136-47

[18] Shiina S,Arano T,Enooku K.Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors..Am J Gastroenterol2011;107:569 PMCID:PMC3321437

[19] Kim YS,Rhim H,Choi D.Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors..J Hepatol2013;58:89-97

[20] Lencioni R,Crocetti L,Pina CD.Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation..Radiology2005;234:961-7

[21] Lee DH,Lee JY,Yoon JH.Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis..Radiology2014;270:900-9

[22] N’Kontchou G,Aout M,Grando V.Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis..Hepatology2009;50:1475-83

[23] Francica G,De Sio I,Brunello F.Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients..Dig Liver Dis2013;45:336-41

[24] Brunello F,Gaia S,Rolle E.Radiofrequency ablation: technical and clinical long-term outcomes for single hepatocellular carcinoma up to 30 mm..Eur J Gastroen Hepat2013;25:842-9

[25] Lin SM,Lin CC,Chen YC.Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm..Gastroenterology2004;127:1714-23

[26] Lin SM,Lin CC,Chen YC.Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less..Gut2005;54:1151-6 PMCID:PMC1774888

[27] Shiina S,Obi S,Tateishi R.A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma..Gastroenterology2005;129:122-30

[28] Lencioni RA,Cioni D,Deibert P.Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection..Radiology2003;228:235-40

[29] Abdelaziz A,Shousha HI,Ibrahim M.Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an Egyptian multidisciplinary clinic experience..Surg Endosc2014;28:3429-34

[30] Shibata T,Yamamoto Y,Ametani F.Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy..Radiology2002;223:331-7

[31] Cannon R,Hayes D,Martin RC2nd.Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures..J Surg Oncol2013;107:544-9

[32] Sutter O,N’Kontchou G,Ourabia R.Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: a retrospective single-center case series..Radiology2017;284:877-86

[33] Fruhling P,Duraj F,Noren A.Single-center nonrandomized clinical trial to assess the safety and efficacy of irreversible electroporation (IRE) ablation of liver tumors in humans: Short to mid-term results..Eur J Surg Oncol2017;43:751-7

[34] EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma..J Hepatol2012;56:908-43

[35] Llovet JM,Montana X,Coll S.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial..Lancet2002;359:1734-9

[36] Lo CM,Tso WK,Lam CM.Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma..Hepatology2002;35:1164-71

[37] Vilgrain V,Assenat E,Ilonca AD.Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial..Lancet Oncol2017;18:1624-36

[38] Chow PKH,Tan SB Khin MW.SIRveNIB: selective internal radiation therapy Versus Sorafenib in Asia-Pacific patients with hepatocellular carcinoma..J Clin Oncol2018;

[39] McDevitt JL,Kapoor B,Gill A.Single-center comparison of overall survival and toxicities in patients with infiltrative hepatocellular carcinoma treated with Yttrium-90 radioembolization or drug-eluting embolic transarterial chemoembolization..J Vasc Interv Radiol2017;28:1371-7

[40] Akinwande O,Edwards J,Philips P.Is radioembolization ((90)Y) better than doxorubicin drug eluting beads (DEBDOX) for hepatocellular carcinoma with portal vein thrombosis? A retrospective analysis..Surg Oncol2015;24:270-5

[41] Moreno-Luna LE,Sanchez W,Harnois DM.Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma..Cardiovasc Intervent Radiol2013;36:714-23 PMCID:PMC3594060

[42] Lance C,Obuchowski N,Levitin A.Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma..J Vasc Interv Radiol2011;22:1697-705

[43] Salem R,Mouli S,Kallini J.Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma..Gastroenterology2016;151:1155-63.e2 PMCID:PMC5124387

[44] Kooby DA,Srinivasan S,Delman KA.Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma..J Vasc Interv Radiol2010;21:224-30

[45] Padia SA,Horton KJ,Kogut MJ.Segmental Yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study..J Vasc Interv Radiol2017;28:777-85.e1

[46] Katsanos K,Spiliopoulos S,Petsas T.Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: a network meta-analysis of randomized controlled trials..PLoS One2017;12:e0184597 PMCID:PMC5608206

[47] Kang JK,Cho CK,Yoo HJ.Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization..Cancer2012;118:5424-31

[48] Bujold A,Kim JJ,Cho C.Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma..J Clin Oncol2013;31:1631-9

[49] Lasley FD,Johnson CS,Althouse S.Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy..Pract Radiat Oncol2015;5:e443-e9

[50] Weiner AA,Ma D,DeWees T.Stereotactic body radiotherapy for primary hepatic malignancies - report of a phase I/II institutional study..Radiother Oncol2016;121:79-85 PMCID:PMC5543719

[51] Takeda A,Tsurugai Y,Matsunaga K.Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation..Cancer2016;122:2041-9

[52] Kim JW,Lee IJ,Han KH.Phase I dose escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma..Oncotarget2016;7:40756-66 PMCID:PMC5130042

[53] Fukumitsu N,Nakayama H,Mizumoto M.A prospective study of hypofractionated proton beam therapy for patients with hepatocellular carcinoma..Int J Radiat Oncol2009;74:831-6

[54] Kawashima M,Nishio T,Ishii H.Phase II study of radiotherapy employing proton beam for hepatocellular carcinoma..J Clin Oncol2005;23:1839-46

[55] Bush DA,Grove R.The safety and efficacy of high-dose proton beam radiotherapy for hepatocellular carcinoma: a phase 2 prospective trial..Cancer2011;117:3053-9

[56] Hong TS,Yeap BY,McDonnell EI.Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma..J Clin Oncol2016;34:460-8 PMCID:PMC4872014

[57] Chen MS,Zheng Y,Liang HH.A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma..Ann Surg2006;243:321-8 PMCID:PMC1448947

[58] Huang J,Cheng Z,Du L.A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria..Ann Surg2010;252:903-12

[59] Feng K,Li X,Ma K.A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma..J Hepatol2012;57:794-802

[60] Ng KKC,Chan ACY,Wong TCL.Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma..Br J Surg2017;104:1775-84

[61] Yin L,Li AJ,Pan ZY.Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a RCT..J Hepatol2014;61:82-8

[62] Yuan BH,Li RH,Gong WF.Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma..Tumour Biol2016;37:2435-41

[63] Liu PH,Lee YH,Huang YH.Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma..J Surg Oncol2015;111:404-9

[64] Zhong JH,Gong WF,Ma L.Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma..Ann Surg2014;260:329-40

[65] Tada T,Toyoda H,Hiraoka A.Role of hepatic resection in patients with intermediate-stage hepatocellular carcinoma: a multicenter study from Japan..Cancer Sci2017;108:1414-20 PMCID:PMC5497930

[66] Hyun MH,Kim JH,Jung YK.Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: a meta-analysis of high-quality studies..Hepatology2018;

[67] Liu PH,Hsu CY,Chiou YY.Survival advantage of radiofrequency ablation over transarterial chemoembolization for patients with hepatocellular carcinoma and good performance status within the Milan criteria..Ann Surg Oncol2014;21:3835-43

[68] Chen RX,Ge NL,Ma H.Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching..J Gastroenterol Hepatol2016;31:442-9

[69] Ishikawa K,Ooka Y,Ogasawara S.Transarterial chemoembolization as a substitute to radiofrequency ablation for treating Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma..Oncotarget2018;9:21560-8 PMCID:PMC5940395

[70] Berger NG,Hammad AY,Mogal H.External radiation or ablation for solitary hepatocellular carcinoma: a survival analysis of the SEER database..J Surg Oncol2017;116:307-12

[71] Wahl DR,Tao Y,Caoili EM.Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma..J Clin Oncol2016;34:452-9 PMCID:PMC4872011

[72] Bush DA,Slater JD,Reeves ME.Randomized clinical trial comparing proton beam radiation therapy with transarterial chemoembolization for hepatocellular carcinoma: results of an interim analysis..Int J Radiat Oncol Biol Phys2016;95:477-82

[73] Gilligan AM,Roe DJ.Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer..Am J Med2018;

[74] Pollom EL,Durkee BY,Mokhtari DA.Cost-effectiveness of stereotactic body radiation therapy versus radiofrequency ablation for hepatocellular carcinoma: a markov modeling study..Radiology2017;283:460-8 PMCID:PMC5410949

[75] Thein H-H,Zaheen A,Sapisochin G.Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world setting..PLOS ONE2017;12:e0185198 PMCID:PMC5634563

[76] Yoon SM,Lee SJ,Shin JH.Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial..JAMA Oncol2018;4:661-9 PMCID:PMC5885246

[77] Honda Y,Aikata H,Fukuhara T.Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma..J Gastroenterol Hepatol2013;28:530-6

[78] Fang Y,Liang X,Lou H.Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma..J Gastroenterol Hepatol2014;29:193-200